The trial will assess the therapy’s pharmacokinetics, pharmacodynamics and safety, as well as its impact on disease activity.

Rheumatoid arthritis (RA) patients face very different risks for cardiovascular disease and events depending on their body ...

Early detection is crucial, as it helps manage symptoms effectively and prevent long-term joint damage. Read on to find out ...

Having psoriasis raises your risk of psoriatic arthritis — and rheumatoid arthritis, too. Make sure you can tell these two forms of arthritis apart.

Systemic sclerosis, or scleroderma, causes the hardening of skin and connective tissues. Often, the disease harms other ...

Cullinan Therapeutics (CGEM) announced that the European Medicines Agency, EMA, approved the Company’s Clinical Trial Application, CTA, for ...

A novel method combining EHR and GWAS data improves prediction of autoimmune disease progression from preclinical stages, ...

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

A major Medicare study shows that while long-term steroid use declines after diagnosis of late-onset rheumatoid arthritis, a ...

A new study published in Heliyon has found that people who experienced abuse, neglect, or domestic abuse during childhood ...

A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.She ...

Psoriatic arthritis represents a complex intersection of immune dysfunction where inflammation targets both skin and joints, ...